KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Receivables (2016 - 2025)

Historic Receivables for Fulgent Genetics (FLGT) over the last 11 years, with Q3 2025 value amounting to $72.6 million.

  • Fulgent Genetics' Receivables rose 2390.37% to $72.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $72.6 million, marking a year-over-year increase of 2390.37%. This contributed to the annual value of $70.8 million for FY2024, which is 3496.22% up from last year.
  • Latest data reveals that Fulgent Genetics reported Receivables of $72.6 million as of Q3 2025, which was up 2390.37% from $79.2 million recorded in Q2 2025.
  • Over the past 5 years, Fulgent Genetics' Receivables peaked at $217.0 million during Q1 2021, and registered a low of $35.7 million during Q2 2023.
  • For the 5-year period, Fulgent Genetics' Receivables averaged around $92.2 million, with its median value being $72.6 million (2025).
  • As far as peak fluctuations go, Fulgent Genetics' Receivables surged by 322794.05% in 2021, and later crashed by 7347.01% in 2023.
  • Over the past 5 years, Fulgent Genetics' Receivables (Quarter) stood at $140.3 million in 2021, then tumbled by 48.27% to $72.6 million in 2022, then decreased by 27.74% to $52.5 million in 2023, then soared by 34.96% to $70.8 million in 2024, then increased by 2.54% to $72.6 million in 2025.
  • Its Receivables stands at $72.6 million for Q3 2025, versus $79.2 million for Q2 2025 and $74.0 million for Q1 2025.